1 | GUSELKUMAB (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 5件: 37 37, 41, 51, 96, 97 💬 |
2 | Guselkumab 100 mg (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 37 37 💬 |
3 | Guselkumab Dose 1 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬 |
4 | Guselkumab Dose 2 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬 |
5 | Guselkumab Dose 3 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬 |
6 | Guselkumab Dose 4 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬 |
7 | Guselkumab Dose 5 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬 |
8 | TREMFYA | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 37 37, 97 💬 |
9 | TREMFYA® | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬 | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 37 37, 97 💬 |